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Introduction
Experimental data show that volatile anesthetics
protect against the consequences of reversible
myocardial ischemia and reperfusion injury.
Clinical studies have been mainly monocentric with
inconsistent results.
Results
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Hypothesis: the use of a volatile anesthetic regimen
is associated with less postoperative myocardial
damage, as evidenced by a lower
troponin T release.
Methods
Multicentre Randomized controlled trial:
8 participating centres in Flanders, Belgium Mortality curves of the 3 different study groups at 1, 
3 and 12 months:
Intravenous
(Group 1)
0,75 ± 1,42 
ng.mL-1
11 days 
(range 5 to 87 days)
7,4 %
Sevoflurane
(Group 2)
0,57 ± 1,03 
ng.mL-1
9 days 
(range 5 to 61 days)
2,5 %
Desflurane
(Group 3)
0,46 ± 0,46 
ng.mL-1
10 days 
(range 5 to 54 days)
2,8 %
Regimen for administration of volatile anesthetics:
starting at a minimal end-tidal concentration of 0,5
MAC at least 30 minutes before the initiation of
myocardial ischemia to at least 10 minutes after the
beginning of reperfusion.
Primary outcome variable: myocardial cell
damage quantified by the area under the curve for
cardiac troponin T blood concentrations over the
first 24 hrs (AUC24hr) and the peak level of troponin
T (Tmax)
Secondary outcome variables: length of hospital
stay ; 30-day and 1-year mortality
Conclusion
The results of this multicenter study on 673 coronary surgery
patients could not demonstrate a lower postoperative
troponin T release when using a volatile anesthetic regimen
(sevoflurane or desflurane) compared with a total
intravenous anesthetic regimen. However, the use of a
volatile anesthetic regimen seemed to be associated with a
shorter hospital length of stay and there was a tendency for
a lower one-year mortality.
*VACMAN study group = Jeroen Huys, Patrick Wouters, Ghent University Hospital, Ghent; Dirk Vlasselaers, Patrick Wouters,  University 
Hospitals Leuven, Leuven; Stefan De Hert, University Hospital Antwerp, Antwerp and University of Amsterdam, Amsterdam; Rob Barbé, Imelda 
Hospital, Bonheiden; Jean-Paul Ory, Jan Dewandere, Virga Jesse Hospital, Hasselt; Dirk De Kegel, Bruno Verhamme, Heilig Hart Hospital, 
Roeselare; Ruggero Donadonni, Eef Delombaerde, Maria Middelares Hospital, Ghent; Jean-Luc Demeere, Sint Jan Hospital, Brussels; Jan 
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